Departure. Clinical Miss. Billion: Should You Bet on Pfizer?
Pfizer faces a trio of headwinds: a CFO departure, a clinical miss, and a billion-dollar bet on Seagen. This article ...
Understand the advantages of choosing no fee high cash back credit cards. Make a financially savvy choice for your wallet.
27,451 articlesPfizer faces a trio of headwinds: a CFO departure, a clinical miss, and a billion-dollar bet on Seagen. This article ...
Memory demand is reshaping the sector, and Micron sits at the center. This guide explains what drives micron technolo...
Rivian remains valued far below Ford despite big hype around electric-vehicle startups. With Rivian’s deliveries risi...
Cineverse is navigating the shifting streaming landscape as it reports 2026 earnings. This guide explains what the nu...
Meta platforms just gave a crucial signal about AI-driven cloud demand. This piece breaks down why Nebius could stand...
Adobe sits as a candidate undervalued stock that could rebound in 2026, trading in the low-$280s with a 16x trailing ...
A high-stakes legal clash between Archer Aviation and Joby could swing how investors price the whole eVTOL space. Her...
MP Materials jumped about 30% in a month, signaling growing investor interest in U.S. rare-earth supply. This article...
Genius Sports reported a significant top-line gain, with revenue up sharply last quarter. But a prominent investor ch...
June brought a high-stakes move in AI infrastructure funding. Super Micro Computer announced a $7B equity financing p...
Honeywell split its aerospace unit into a new company, and the initial market reaction gave investors plenty to study...
Novo Nordisk faces challenges, but three strong catalysts could propel the stock higher. This article breaks down the...